Click for best price
Viral Pneumonia Treatment Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Viral Pneumonia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Pneumonia Treatment Drugs. This report contains market size and forecasts of Viral Pneumonia Treatment Drugs in global, including the following market information:
Global Viral Pneumonia Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Viral Pneumonia Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Ribavirin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Pneumonia Treatment Drugs include Roche, GlaxoSmithKline, Pfizer, Novartis, Johnson and Johnson and Teva Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Pneumonia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Pneumonia Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Viral Pneumonia Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Ribavirin
Acyclovir
Ganciclovir
Others
Global Viral Pneumonia Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Viral Pneumonia Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Viral Pneumonia Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Viral Pneumonia Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Pneumonia Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Viral Pneumonia Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
GlaxoSmithKline
Pfizer
Novartis
Johnson and Johnson
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Pneumonia Treatment Drugs, market overview.
Chapter 2: Global Viral Pneumonia Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Viral Pneumonia Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Pneumonia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Pneumonia Treatment Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Pneumonia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Pneumonia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Pneumonia Treatment Drugs Overall Market Size
2.1 Global Viral Pneumonia Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Viral Pneumonia Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Pneumonia Treatment Drugs Players in Global Market
3.2 Top Global Viral Pneumonia Treatment Drugs Companies Ranked by Revenue
3.3 Global Viral Pneumonia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Viral Pneumonia Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Pneumonia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Pneumonia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Viral Pneumonia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Pneumonia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Pneumonia Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Ribavirin
4.1.3 Acyclovir
4.1.4 Ganciclovir
4.1.5 Others
4.2 By Type - Global Viral Pneumonia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Viral Pneumonia Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Viral Pneumonia Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Pneumonia Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Viral Pneumonia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Viral Pneumonia Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Viral Pneumonia Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Viral Pneumonia Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Viral Pneumonia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Viral Pneumonia Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Viral Pneumonia Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Viral Pneumonia Treatment Drugs Revenue, 2018-2029
6.3.2 US Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Viral Pneumonia Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.3 France Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Viral Pneumonia Treatment Drugs Revenue, 2018-2029
6.5.2 China Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.5.6 India Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Viral Pneumonia Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Pneumonia Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Viral Pneumonia Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Viral Pneumonia Treatment Drugs Market Size, 2018-2029
7 Viral Pneumonia Treatment Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Viral Pneumonia Treatment Drugs Major Product Offerings
7.1.4 Roche Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Viral Pneumonia Treatment Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Viral Pneumonia Treatment Drugs Major Product Offerings
7.3.4 Pfizer Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Viral Pneumonia Treatment Drugs Major Product Offerings
7.4.4 Novartis Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Johnson and Johnson
7.5.1 Johnson and Johnson Company Summary
7.5.2 Johnson and Johnson Business Overview
7.5.3 Johnson and Johnson Viral Pneumonia Treatment Drugs Major Product Offerings
7.5.4 Johnson and Johnson Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson and Johnson Key News & Latest Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Viral Pneumonia Treatment Drugs Major Product Offerings
7.6.4 Teva Pharmaceutical Viral Pneumonia Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral Pneumonia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Viral Pneumonia Treatment Drugs Market Drivers in Global Market
Table 3. Viral Pneumonia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Viral Pneumonia Treatment Drugs in Global Market
Table 5. Top Viral Pneumonia Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Viral Pneumonia Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Viral Pneumonia Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Viral Pneumonia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Viral Pneumonia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Pneumonia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Viral Pneumonia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Viral Pneumonia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Viral Pneumonia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Viral Pneumonia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Viral Pneumonia Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Viral Pneumonia Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Viral Pneumonia Treatment Drugs Product Offerings
Table 32. Roche Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Viral Pneumonia Treatment Drugs Product Offerings
Table 36. GlaxoSmithKline Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Viral Pneumonia Treatment Drugs Product Offerings
Table 40. Pfizer Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Viral Pneumonia Treatment Drugs Product Offerings
Table 44. Novartis Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Johnson and Johnson Company Summary
Table 47. Johnson and Johnson Viral Pneumonia Treatment Drugs Product Offerings
Table 48. Johnson and Johnson Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson and Johnson Key News & Latest Developments
Table 50. Teva Pharmaceutical Company Summary
Table 51. Teva Pharmaceutical Viral Pneumonia Treatment Drugs Product Offerings
Table 52. Teva Pharmaceutical Viral Pneumonia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Viral Pneumonia Treatment Drugs Segment by Type in 2022
Figure 2. Viral Pneumonia Treatment Drugs Segment by Application in 2022
Figure 3. Global Viral Pneumonia Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral Pneumonia Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Viral Pneumonia Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Pneumonia Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Viral Pneumonia Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Viral Pneumonia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson and Johnson Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceutical Viral Pneumonia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
